Results of your search

    18 Results
  • Ellen Strahlman - Director - has a Master in Clinical Epidemiology and Biostatistics from Johns Hopkins School of Medicine and Doctor of Medicine from Johns Hopkins University School of Medicine.
  • Michael Kauffman - Director - has a PhD in Molecular Biology and Biochemistry from Johns Hopkins School of Medicine.
  • Marc Grasso - Chief Financial Officer - has a Medical Docctorate from Johns Hopkins School of Medicine and Degree in Molecular Biology from Princeton University.
  • Tamara Elias - Director - has a Medical Doctorate from Johns Hopkins School of Medicine and Degrees in Biology and Anthropology from Yale University.
  • Michael Kauffman - Director - has a PhD in Molecular Biology and Biochemistry from Johns Hopkins School of Medicine.
    Kezar Life Sciences - Biotechnology - United States (USA)
  • Michael Kauffman - Chief Executive Officer - has a PhD in Molecular Biology and Biochemistry from Johns Hopkins School of Medicine.
    Nereid Therapeutics - Biotechnology - United States (USA)
  • Michael Kauffman - Lead Director - has a PhD in Molecular Biology and Biochemistry from Johns Hopkins School of Medicine.
    Verastem Oncology - Biotechnology - United States (USA)
  • Roger Pomerantz - Chairman of The Board - has a Medical Doctor from Johns Hopkins School of Medicine and Bachelor in Biochemistry from Johns Hopkins University.
    Viracta Therapeutics - Biotechnology - United States (USA)
  • Tamara Elias - Director - has a Medical Doctorate from Johns Hopkins School of Medicine and Degrees in Biology and Anthropology from Yale University.
  • Roger Pomerantz - Vice Chairman of the Board - has a Medical Doctor from Johns Hopkins School of Medicine and Bachelor in Biochemistry from Johns Hopkins University.
    Enlivex Therapeutics - Biotechnology - Israel
  • Ellen Strahlman - Director - has a Master in Clinical Epidemiology and Biostatistics from Johns Hopkins School of Medicine and Doctor of Medicine from Johns Hopkins University School of Medicine.
  • Roger Pomerantz - Chairman of the Board - has a Medical Doctor from Johns Hopkins School of Medicine and Bachelor in Biochemistry from Johns Hopkins University.
    CollPlant Biotechnologies - Biotechnology - Israel
  • Josh Groman - Deputy Chief Investment Officer - has a Doctor of Philosophy in Medical Genetics and Molecular Biology from Johns Hopkins School of Medicine.
  • Marisa Cruz - Chief Medical Officer - has a Doctor of Medicine from Johns Hopkins School of Medicine and Bachelor in Neuroscience from Johns Hopkins University.
  • Mark Sausen - Head of Technology Innovation - has a PhD in Cellular and Molecular Medicine from Johns Hopkins School of Medicine and Bachelor of Arts in Biological and Physical Sciences from University of Delaware.
    Personal Genome Diagnostics - Biotechnology - United States (USA)
  • Roger Pomerantz - Chairman of the Board - has a Medical Doctor from Johns Hopkins School of Medicine and Bachelor in Biochemistry from Johns Hopkins University.
    Indaptus Therapeutics - Biotechnology - Israel
  • Michael Kauffman - Chairman of the Board - has a PhD in Molecular Biology and Biochemistry from Johns Hopkins School of Medicine.
    Parthenon Therapeutics - Biotechnology - United States (USA)
  • Tamara Elias - Director - has a Medical Doctorate from Johns Hopkins School of Medicine and Degrees in Biology and Anthropology from Yale University.

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.